Double-blind randomised placebo-controlled cross-over study to investigate the safety and effectiveness of intrathecal glycine on pain and dystonia in Complex Regional Pain Syndrome type 1.
Completed
- Conditions
- Complex Regional Pain Syndrome type 1 (CRPS I)
- Registration Number
- NL-OMON27048
- Lead Sponsor
- Dept. of Neurology, Leiden University Medical Centre
- Brief Summary
/A
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 20
Inclusion Criteria
1. Patients must fulfil the diagnostic criteria of the consensus report of CRPS I:
a. continuing pain, allodynia or hyperalgesia, in which the pain is disproportionate to any inciting event;
Exclusion Criteria
1. Patients are excluded if they can obtain satisfactory relief of symptoms with conventional treatments;
2. Patients with a history of alcohol or drugs abuse within the past year;
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method